Panel
Executing a Successful Overseas Listing: Lessons Learned and Implications
Time
13:00-16:30 on March 6, 2019
Venue
Room 1 @ The St. Regis Shanghai Jingan
00
-
10
10
-
40
Speaker:
Andrew Yu, Consulting Managing Partner, Deloitte China Life Sciences and Healthcare
40
-
40
Topics:
(1) Pre-IPO Crossover Financing Round;
(2) Capital Market Response from Recent Biotech IPOs;
(3) Key Execution Lessons from Recent IPOs.
Speakers:
Andy Wu, Head of Morgan Stanley APAC Healthcare IBD, Managing Director;
Samuel Thong, M.D., Morgan Stanley Senior Advisor;
Cathy Zhang, Morgan Stanley Global Capital Markets, Managing Director;
Kenneth Sun, Morgan Stanley APAC Healthcare IBD, Executive Director
40
-
00
Speaker: Alan Hu, Audit & Assurance Managing Partner, Deloitte China Life Sciences and Healthcare
00
-
20
Speaker: Bob Chen, Deloitte China Financial Advisory Partner
20
-
00
Speakers:
James Zhao, Tax & Legal Managing Partner, Deloitte China Life Sciences and Healthcare;
Anna Chen, Deloitte China Financial Advisory Partner;
Irene Yu, Deloitte China Financial Advisory Partner;
Vivian Li, Deloitte China Financial Advisory Senior Manager
00
-
20
20
-
30
Morgan Stanley is a leading global financial services firm providing a wide range of investment banking, securities, wealth management and investment management services. With offices in more than 41 countries, the Firm's employees serve clients worldwide including corporations, governments, institutions and individuals. For further information about Morgan Stanley, please visit www.morganstanley.com.